MIR92A2: A Potential Drug Target and Biomarker (G407049)

Target Name: MIR92A2

NCBI ID: G407049

MIR92A2

MIR92A2: A Potential Drug Target and Biomarker

MIR92A2, also known as mir-92a-2, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of cell proliferation and has been shown to play a critical role in the development and progression of various diseases, including cancer. In this article, we will discuss the research on MIR92A2, its potential as a drug target, and its potential as a biomarker for various diseases.

MIR92A2: A Potential Drug Target

MIR92A2 is a non-coding RNA molecule that is expressed in various tissues and cells of the body. It is a key regulator of cell proliferation and has been shown to play a critical role in the development and progression of various diseases, including cancer. MIR92A2 has been shown to promote the growth and proliferation of cancer cells, and it has also been shown to contribute to the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

One of the reasons why MIR92A2 has been identified as a potential drug target is its role in the regulation of cell proliferation. MIR92A2 has been shown to promote the growth and proliferation of cancer cells by increasing the levels of the transcriptional factor, p53. p53 is a well-known tumor suppressor gene that plays a critical role in the regulation of cell proliferation and has been shown to be involved in the development and progression of various diseases, including cancer.

Another reason why MIR92A2 has been identified as a potential drug target is its role in the regulation of cell apoptosis. MIR92A2 has been shown to contribute to the regulation of cell apoptosis, which is the process by which cells undergo programmed cell death. MIR92A2 has been shown to promote the survival of cancer cells by increasing the levels of the protein, Bcl-2. Bcl-2 is a well-known tumor suppressor protein that has been shown to play a critical role in the regulation of cell apoptosis.

MIR92A2: A Potential Biomarker

MIR92A2 has also been identified as a potential biomarker for various diseases. One of the reasons why MIR92A2 has been shown as a potential biomarker is its role in the regulation of cell proliferation. MIR92A2 has been shown to promote the growth and proliferation of cancer cells, which could be used as a biomarker for cancer diagnosis and treatment.

Another reason why MIR92A2 has been shown as a potential biomarker is its role in the regulation of cell apoptosis. MIR92A2 has been shown to contribute to the regulation of cell apoptosis, which is the process by which cells undergo programmed cell death. MIR92A2 has been shown to promote the survival of cancer cells by increasing the levels of the protein, Bcl-2. Bcl-2 is a well-known tumor suppressor protein that has been shown to play a critical role in the regulation of cell apoptosis.

MIR92A2 has also been shown as a potential biomarker for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. MIR92A2 has been shown to promote the growth and proliferation of neurodegenerative disease cells and it has also been shown to contribute to the development of neurodegenerative diseases.

Conclusion

MIR92A2 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of cell proliferation and has been shown to play

Protein Name: MicroRNA 92a-2

The "MIR92A2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR92A2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets